Biomerica Inc (BMRA)

$0.64 -0.07 (-9.35%)
Market Cap 12.95M
Revenue (ttm) 5.42M
Net Income (ttm) -5.98M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -110.33%
Debt to Equity Ratio 0.00
Volume 11,635,200
Avg Vol 9,205,698
Day's Range N/A - N/A
Shares Out 18.34M
Stochastic %K 34%
Beta -1.04
Analysts Strong Buy
Price Target $13.00

Latest News on BMRA

Biomerica Stock Trades 200% Higher After Prostate Screening Test Receives Approval

Jan 16, 2025, 10:49 AM EST - 1 day ago

Biomerica Stock Trades 200% Higher After Prostate Screening Test Receives Approval

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® PSA Screening Test to Detect an Early Sign of Prostate Cancer

Jan 16, 2025, 8:19 AM EST - 1 day ago

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® PSA Screening Test to Detect an Early Sign of Prostate Cancer

Biomerica Reports Second Quarter Fiscal 2025 Financial Results

Jan 15, 2025, 8:19 AM EST - 2 days ago

Biomerica Reports Second Quarter Fiscal 2025 Financial Results

Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn's Disease, and Ulcerative Colitis

Nov 21, 2024, 8:19 AM EST - 2 months ago

Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn's Disease, and Ulcerative Colitis

Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements

Nov 7, 2024, 9:09 AM EST - 2 months ago

Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements

Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain

Oct 30, 2024, 8:19 AM EDT - 2 months ago

Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain

Biomerica Reports First Quarter Fiscal 2025 Financial Results

Oct 16, 2024, 9:00 AM EDT - 3 months ago

Biomerica Reports First Quarter Fiscal 2025 Financial Results

The Saudi Food and Drug Authority (SFDA) Approves Biomerica's At Home PSA Screening Test to Detect Early Signs of Prostate Cancer

Sep 4, 2024, 8:19 AM EDT - 4 months ago

The Saudi Food and Drug Authority (SFDA) Approves Biomerica's At Home PSA Screening Test to Detect Early Signs of Prostate Cancer

Biomerica Reports Fiscal 2024 Year End Results

Aug 29, 2024, 9:00 AM EDT - 5 months ago

Biomerica Reports Fiscal 2024 Year End Results

Biomerica Launches At-Home Sample Collection for inFoods® IBS, Significantly Expanding Access for Millions of IBS Sufferers

Jul 1, 2024, 7:47 AM EDT - 7 months ago

Biomerica Launches At-Home Sample Collection for inFoods® IBS, Significantly Expanding Access for Millions of IBS Sufferers

Biomerica Announces inFoods® IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024

May 13, 2024, 8:19 AM EDT - 8 months ago

Biomerica Announces inFoods® IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024

Biomerica and Leading UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement

Apr 29, 2024, 8:19 AM EDT - 9 months ago

Biomerica and Leading UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement

Biomerica provides update on inFoods® IBS expansion

Apr 15, 2024, 7:47 AM EDT - 9 months ago

Biomerica provides update on inFoods® IBS expansion

Biomerica Reports Third Quarter 2024 Financial Results

Apr 12, 2024, 7:23 PM EDT - 10 months ago

Biomerica Reports Third Quarter 2024 Financial Results

Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference

Mar 28, 2024, 8:19 AM EDT - 10 months ago

Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference

Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board

Feb 21, 2024, 8:19 AM EST - 11 months ago

Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board

Diagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at Biomerica

Jan 23, 2024, 8:19 AM EST - 1 year ago

Diagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at Biomerica

Biomerica Reports Second Quarter 2024 Financial Results

Jan 16, 2024, 8:19 AM EST - 1 year ago

Biomerica Reports Second Quarter 2024 Financial Results

Biomerica Received US FDA 510(k) Clearance for Their Hp Detect™ ELISA Test Product Designed to Detect the Presence of the H. pylori Bacteria That infects Approximately 35% of the U.S. Population

Dec 18, 2023, 7:47 AM EST - 1 year ago

Biomerica Received US FDA 510(k) Clearance for Their Hp Detect™ ELISA Test Product Designed to Detect the Presence of the H. pylori Bacteria That infects Approximately 35% of the U.S. Population

Biomerica to Participate in 14th Annual Craig-Hallum Alpha Select Conference on November 16

Nov 10, 2023, 8:19 AM EST - 1 year ago

Biomerica to Participate in 14th Annual Craig-Hallum Alpha Select Conference on November 16

Biomerica Expands inFoods IBS Reach with Addition of Several New GI Groups

Nov 8, 2023, 8:19 AM EST - 1 year ago

Biomerica Expands inFoods IBS Reach with Addition of Several New GI Groups

REPEAT - Biomerica Reports First Quarter 2024 Financial Results

Oct 13, 2023, 1:10 PM EDT - 1 year ago

REPEAT - Biomerica Reports First Quarter 2024 Financial Results

Biomerica Reports First Quarter 2024 Financial Results

Oct 13, 2023, 6:39 AM EDT - 1 year ago

Biomerica Reports First Quarter 2024 Financial Results

Dubai Government Grants Insurance Reimbursement for Biomerica's EZ Detect™ Colorectal Disease Screening Test

Sep 26, 2023, 8:19 AM EDT - 1 year ago

Dubai Government Grants Insurance Reimbursement for Biomerica's EZ Detect™ Colorectal Disease Screening Test

Diagnostics Industry Leader Jack Kenny Joins Biomerica's Board of Directors

Aug 28, 2023, 8:19 AM EDT - 1 year ago

Diagnostics Industry Leader Jack Kenny Joins Biomerica's Board of Directors

Biomerica Reports Fiscal 2023 Year End Results

Aug 25, 2023, 5:00 PM EDT - 1 year ago

Biomerica Reports Fiscal 2023 Year End Results

CVS Health to Begin Nationwide In-Store Sales of Biomerica's EZ Detect™ Colorectal Disease Screening Test

Aug 3, 2023, 8:19 AM EDT - 1 year ago

CVS Health to Begin Nationwide In-Store Sales of Biomerica's EZ Detect™ Colorectal Disease Screening Test

Biomerica Receives Notice of Patent Allowance in China for a Potential Innovative Technology That Includes an Artificial Intelligence (AI) Claim for Predicting Foods That Contain Ingredients That Cause Adverse Reactions in Patients

Jun 21, 2023, 8:19 AM EDT - 1 year ago

Biomerica Receives Notice of Patent Allowance in China for a Potential Innovative Technology That Includes an Artificial Intelligence (AI) Claim for Predicting Foods That Contain Ingredients That Cause Adverse Reactions in Patients

inFoods® IBS Test Now Validated for Use with Simple Finger Stick Whole Blood Collection Technology

May 18, 2023, 8:19 AM EDT - 1 year ago

inFoods® IBS Test Now Validated for Use with Simple Finger Stick Whole Blood Collection Technology

Biomerica's inFoods® IBS test is now available at Gastro Health, providing a revolutionary new treatment for patients suffering from Irritable Bowel Syndrome (IBS).

Apr 17, 2023, 7:47 AM EDT - 1 year ago

Biomerica's inFoods® IBS test is now available at Gastro Health, providing a revolutionary new treatment for patients suffering from Irritable Bowel Syndrome (IBS).

Biomerica Reports Q3 Fiscal 2023 Results

Apr 14, 2023, 4:48 PM EDT - 1 year ago

Biomerica Reports Q3 Fiscal 2023 Results

Biomerica announces the Launch of InFoods IBS as a Laboratory Developed Test (LDT); First patient samples have been processed

Mar 8, 2023, 8:19 AM EST - 2 years ago

Biomerica announces the Launch of InFoods IBS as a Laboratory Developed Test (LDT); First patient samples have been processed

Biomerica Announces Closing of $8 Million Underwritten Public Offering of Common Stock

Mar 7, 2023, 4:39 PM EST - 2 years ago

Biomerica Announces Closing of $8 Million Underwritten Public Offering of Common Stock

Biomerica Announces Pricing of $8 Million Underwritten Public Offering of Common Stock

Mar 3, 2023, 7:30 AM EST - 2 years ago

Biomerica Announces Pricing of $8 Million Underwritten Public Offering of Common Stock

Biomerica Announces Proposed Underwritten Public Offering of Common Stock

Mar 2, 2023, 5:15 PM EST - 2 years ago

Biomerica Announces Proposed Underwritten Public Offering of Common Stock

Biomerica Reports Financial Results for Fiscal 2023 Second Quarter Ended November 30, 2022

Jan 13, 2023, 6:39 PM EST - 2 years ago

Biomerica Reports Financial Results for Fiscal 2023 Second Quarter Ended November 30, 2022

Biomerica Appoints Mayo Clinic Gastroenterologist, Dr. Brian E. Lacy, to the Company's Scientific Advisory Board

Jan 10, 2023, 8:19 AM EST - 2 years ago

Biomerica Appoints Mayo Clinic Gastroenterologist, Dr. Brian E. Lacy, to the Company's Scientific Advisory Board

Biomerica Receives KFDA and Ministry of Health Approval for Colorectal Screening and Breast Screening Tests in Saudi Arabia and UAE

Dec 8, 2022, 8:19 AM EST - 2 years ago

Biomerica Receives KFDA and Ministry of Health Approval for Colorectal Screening and Breast Screening Tests in Saudi Arabia and UAE

Biomerica InFoods® IBS Data Presented at the 2022 American College of Gastroenterology (ACG) Annual Scientific Meeting

Nov 2, 2022, 8:19 AM EDT - 2 years ago

Biomerica InFoods® IBS Data Presented at the 2022 American College of Gastroenterology (ACG) Annual Scientific Meeting

Biomerica stock leaps as Walmart expands sales of Aware Breast Self Exam to its stores

Oct 14, 2022, 9:46 AM EDT - 2 years ago

Biomerica stock leaps as Walmart expands sales of Aware Breast Self Exam to its stores

Walmart to Expand Sales of Biomerica's Aware® Breast Self Exam; Product will now be available in over 2400 Walmart stores

Oct 14, 2022, 9:18 AM EDT - 2 years ago

Walmart to Expand Sales of Biomerica's Aware® Breast Self Exam; Product will now be available in over 2400 Walmart stores

Biomerica Reports 30% Increase in Revenues for Fiscal Q1 2023 vs. Fiscal Q1 2022

Oct 13, 2022, 4:50 PM EDT - 2 years ago

Biomerica Reports 30% Increase in Revenues for Fiscal Q1 2023 vs. Fiscal Q1 2022

Biomerica Plans Launch of InFoods® IBS Test; Names Robert Carlson as Chief Commercial Officer

Aug 30, 2022, 8:19 AM EDT - 2 years ago

Biomerica Plans Launch of InFoods® IBS Test; Names Robert Carlson as Chief Commercial Officer

Biomerica Reports Fiscal 2022 Year End Results

Aug 29, 2022, 4:41 PM EDT - 2 years ago

Biomerica Reports Fiscal 2022 Year End Results

Walmart to Start Selling Biomerica's Aware Breast Self Exam Devices

Jul 14, 2022, 11:59 AM EDT - 2 years ago

Walmart to Start Selling Biomerica's Aware Breast Self Exam Devices

Walmart to Begin Selling Biomerica's Aware® Breast Self Exam

Jul 14, 2022, 8:19 AM EDT - 2 years ago

Walmart to Begin Selling Biomerica's Aware® Breast Self Exam

Biomerica to Participate at BTIG Biotech Conference

Jun 23, 2022, 8:19 AM EDT - 2 years ago

Biomerica to Participate at BTIG Biotech Conference

Biomerica Announces CE Mark for Its H. pylori Diagnostic Test, hp+detect™

May 12, 2022, 8:19 AM EDT - 2 years ago

Biomerica Announces CE Mark for Its H. pylori Diagnostic Test, hp+detect™

Biomerica Announces FDA Submission For a Test to Detect Helicobacter pylori (H. pylori), a Bacteria That Infects Approximately 35% of the US Population

Apr 26, 2022, 8:19 AM EDT - 2 years ago

Biomerica Announces FDA Submission For a Test to Detect Helicobacter pylori (H. pylori), a Bacteria That Infects Approximately 35% of the US Population

Biomerica Reports 111% Increase in Q3 Fiscal 2022 Revenues to $7.6 million vs. Q3 Fiscal 2021

Apr 14, 2022, 8:37 AM EDT - 3 years ago

Biomerica Reports 111% Increase in Q3 Fiscal 2022 Revenues to $7.6 million vs. Q3 Fiscal 2021